0.41
+1.23%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About MustGrow Biologics
Its shares trade on TSX Venture under the ticker MGRO.V. It has been listed since 10 July 2019. In the fiscal year to 31 December 2025, it reported revenue of C$8.3m and a net loss of C$7.3m. At that date it held total assets of C$3.1m and shareholders' equity of C$867,100.
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2019-07-10. The firm is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. The company focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The firm is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The firm is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 10 Jul 2019
- Website
- mustgrow.ca ↗
Leadership
Pay as last reported
- Mr. Bradley MunroIndependent Chairman of the Board
- Mr. Corey GiassonChief Executive Officer, Director, since 2018C$315,706
- Mr. Todd LahtiChief Financial Officer, Corporate SecretaryC$289,397
- Mr. Colin BletskyChief Operating Officer, Director, since 2018C$302,551
- Mr. David BoreckyIndependent Director
- Mr. Thomas FlowIndependent Director
- Mr. Matt KowalskiIndependent DirectorC$17,464
- Ms. Laura WestbyIndependent DirectorC$15,257
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MustGrow Biologics Corp. develops natural biopesticides from mustard seed for sustainable agriculture.
- The company focuses on organic biocontrol and soil amendment products with synthetic chemical efficacy.
- MustGrow's technology pipeline includes soil amendment, bio fertility, and postharvest biocontrol applications.
Weaknesses
- MustGrow Biologics Corp. currently employs 0 full-time employees despite being listed since 2019.
- The company has no full-time staff to support its development and commercialization efforts.
- MustGrow's IPO in 2019 has not resulted in a significant workforce for operations.
Opportunities
- MustGrow targets sustainable agricultural markets with natural biopesticide solutions.
- The firm aims to expand in soil amendment and bio fertility markets globally.
- Global food supply sustainability drives demand for MustGrow's organic technologies.
Threats
- MustGrow's lack of full-time employees may hinder market adoption and product development.
- The company's reliance on mustard seed technology faces competition from synthetic alternatives.
- Global market volatility could impact the adoption of natural biopesticide products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.